5422W-13 A clinical trial to evaluate the safety and effectiveness of the Absolute Pro® (and Absolut

A clinical trial to evaluate the safety and effectiveness of the Absolute Pro® (and Absolute Pro® LL) Peripheral Self-Expanding Stent Systems in the treatment of atherosclerotic or restenotic lesions in the femoral and popliteal arteries (MOMENTUM)

Type of Study
Heart & Vascular - Peripheral Trials
Short Description

To determine the safety and effectiveness of the Absolute ProR Peripheral Self-Expanding Stent System and the Absolute ProR LL Peripheral Self-Expanding Stent System for the treatment of subjects with atherosclerotic de novo or restenotic lesions in the native superficial femoral artery and/or the native proximal popliteal artery.

Status
Open
Principal Investigator
Robert Bersin, MD
Eligibility Notes
  • Adult male and female subjects with a single de novo or restenotic [not previously treated] native disease segment of the superficial femoral artery and/or proximal popliteal artery.
  • Inability to walk, organ transplant(received or pending), and recent non-iliac percutaneous interventions are all exclusionary.
Contact Name
Jeremy Gillis and Jennifer Nagel
Phone
206-215-2437
Alternate Phone
206-386-6462
Email
jeremy.gillis@swedish.org
Alternate Email
jennifer.nagel@swedish.org